Among the many prescription drugs listed, one notable entry is for the oral hypoglycemic agent
metformin that today is among the most widely used drugs for treating type 2 diabetes and is especially relevant for HF patients because, as the statement notes, 38% also have diabetes.
Up to date, even preparations used in clinical trials are not of standardized formulation,  indicating that a well-formulated preparation that is effective as a hypoglycemic agent
, far more in terms of safety, has not been identified yet.
incisa is used for the treatment of heart disease and as a hypoglycemic agent
OSA technology captures the most bioactive parts of the Gymnema sylvestre leaf and produces an isolate with a specified molecular weight, which mimics a hypoglycemic agent
In the streptozotocin-induced type 2 diabetic rats, [beta]-amyrin palmitate at 50[micro]g/kg significantly reduced serum glucose levels and at a better rate than the standard oral hypoglycemic agent
A 47-year-old woman with type 2 diabetes mellitus who had been treated with a sulfonylurea for 10 years began experiencing frequent episodes of hypoglycemia even after complete withdrawal of the hypoglycemic agent
This one takes the cake: 6 antipsychotics (2 typicals and 4 atypicals), plus an anticholinergic, 3 mood stabilizers, 2 antidepressants, 2 sleeping pills, a hypoglycemic agent
, 2 antihypertensives, and a statin.
In addition, the primary anthocyanin contained in the anthocyanin-enriched extract, malvidin-3-O-glucoside, was an active hypoglycemic agent
when administered as a pure compound while another abundant anthocyanin from the extract, delphinidin-3-O-glucoside, did not show significant bioactivity.
12 JAMA study, researchers followed 159,026 people age 66 or older who were taking at least one oral hypoglycemic agent
for type 2 diabetes.
The study was carried out with pure saponin, which was previously extracted from the balamites fruit mesocarp, and the water extract of saponin was used as an oral hypoglycemic agent
Tokyo, Japan, Jan 30, 2006 - (JCN) - Ajinomoto and Astellas Pharma jointly announced on January 27 that they have filed a supplemental New Drug Application (SNDA) for FASTIC Tablet/STARSIS Tablet (nateglinide), a fast-acting postprandial hypoglycemic agent
co-developed by the two companies.